Anti-PCOLCE (PCPE-1) Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibody raised against the CUB-2 domain of human PCOLCE (PCPE-1), validated for Western blot applications.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential
UniProt
Q15113
Size
100ug
Cat. #
RP1PCOLE1

In stock

SKU
RP-PCOLE1

Options

As low as: $130.00

Target Overview

Procollagen C-endopeptidase enhancer 1 (PCOLCE, PCPE-1; UniProt Q15113) is a 449-residue secreted glycoprotein that binds to the C-terminal propeptide of type I procollagen and potentiates the activity of procollagen C-proteinase (BMP-1/tolloid-like proteinases). The protein contains two CUB domains and a netrin-like (NTR) domain, structural features characteristic of the PCPE family. By enhancing cleavage of the C-propeptide from procollagen, PCPE-1 facilitates the conversion of soluble procollagen into insoluble collagen fibrils, a critical step in extracellular matrix assembly. PCPE-1 is expressed in connective tissues undergoing active collagen synthesis, including bone, cartilage, skin, and vascular tissues. The protein has been implicated in fibrotic remodeling, wound healing, and scar formation, where dysregulated collagen processing contributes to tissue pathology. Recent sequence comparisons have highlighted functional divergence between PCPE-1 and its paralog PCPE-2 despite high sequence similarity, underscoring the specificity of PCPE-1 in type I collagen maturation pathways.

Background

PCOLCE functions as a non-enzymatic cofactor in the extracellular processing of fibrillar procollagens. Upon secretion, procollagen molecules retain N- and C-terminal propeptides that prevent premature fibril assembly. BMP-1 and related metalloproteases cleave these propeptides, but their activity on the C-terminus is rate-limiting in the absence of enhancer proteins. PCPE-1 binds directly to the C-propeptide of type I and type II procollagen, positioning the substrate for efficient proteolysis and accelerating cleavage kinetics by an order of magnitude. This enhancer function is domain-specific: the CUB-2 domain mediates propeptide binding, while the NTR domain contributes to stability and secretion. Loss of PCPE-1 activity results in the accumulation of partially processed procollagen and abnormal fibril morphology, as observed in certain connective tissue disorders. PCPE-1 has emerged as a marker and potential mediator of pathological fibrosis. Zhang et al (2026) identified dual fibroblast populations in spinal cord injury models, with PCOLCE upregulated in fibrous scar-forming subsets, suggesting its involvement in post-traumatic extracellular matrix remodeling. Genome-wide Mendelian randomization studies have implicated PCOLCE genetic variants in pelvic organ prolapse susceptibility, reflecting its role in pelvic floor connective tissue integrity. The protein has also been cataloged in gene expression signatures associated with gastric cancer prognosis and bladder cancer mitochondrial stress responses, although its functional contribution to tumorigenesis remains under investigation. A recent review by Sorci-Thomas et al (2026) emphasizes that despite 60% sequence identity, PCPE-1 and PCPE-2 exhibit distinct tissue distributions and substrate preferences, cautioning against extrapolating findings between paralogs. The RP1PCOLE1 antibody targets the CUB-2 domain, the functional epitope responsible for procollagen propeptide recognition, making it suitable for studies of collagen processing, fibrotic disease models, and extracellular matrix remodeling in human tissues.

References

  1. Zhang Z et al (2026) Dual role of fibroblasts in fibrous scar formation after spinal cord injury: Single-cell sequencing and experimental verification. Neural Regen Res. PubMed · DOI
  2. Sorci-Thomas MG et al (2026) PCPE1 and PCPE2: When Sequence Similarity Masks Functional Diversity. Arterioscler Thromb Vasc Biol. PubMed · DOI
  3. Liu X et al (2025) Identification of Novel Disease-Modifying Agents for Pelvic Organ Prolapse by Systematic Druggable Genome-Wide Mendelian Randomization. Int J Womens Health. PubMed · DOI

Additional Specifications

Gene Symbol PCOLCE2
UniProt ID Q15113
Host Species Rabbit
Species Reactivity Validated- Human
Potential
Pack Size 100ug
Immunogen Immunogen is proprietary and confidential. Immunogen generated in amino acid region 159-273.
Alternate Names PCOLCE, PCPE-1, Procollagen C-endopeptidase enhancer 1, Procollagen COOH-terminal proteinase enhancer 1, Procollagen C-proteinase enhancer 1, Type 1 procollagen C-proteinase enhancer protein, Type I procollagen COOH-terminal proteinase enhancer

Frequently Asked Questions

What is the expected molecular weight for PCOLCE-1 on Western blot?

PCOLCE-1 migrates at approximately 48–55 kDa on reducing SDS-PAGE, slightly higher than the predicted 48 kDa for the 449-residue polypeptide due to N-linked glycosylation. You may observe a diffuse band or minor size heterogeneity reflecting variable glycosylation states, which is typical for this secreted glycoprotein. If you treat lysates with PNGase F or other deglycosylating enzymes, the band should sharpen and migrate closer to 48 kDa. Conditioned medium from fibroblasts or osteoblasts usually gives a cleaner signal than whole-cell lysates because PCOLCE-1 is secreted.

What dilution should I start with for PCOLCE-1 Western blot and IHC?

For Western blot, start at 1:1000 in 5% non-fat milk or BSA in TBST, which is the validated dilution for this antibody. For IHC on formalin-fixed paraffin-embedded sections, begin at 1:200 to 1:500 after antigen retrieval in citrate buffer, pH 6.0. Because PCOLCE-1 is a secreted protein, you may need to optimize blocking conditions and incubation time to reduce background in extracellular matrix-rich tissues. Always include a no-primary control and, if possible, a tissue known to express PCOLCE-1 such as skin or bone.

Does this antibody detect mouse or rat PCOLCE-1, or only human?

This antibody is validated for human PCOLCE-1. Cross-reactivity with mouse and rat is predicted based on sequence homology—human PCOLCE shares roughly 85–90% identity with mouse and rat orthologs across the CUB and netrin-like domains—but has not been experimentally confirmed by us. If you plan to use mouse or rat samples, we recommend running a positive control lysate from human cells in parallel and verifying band size and specificity. Titre the antibody starting at 1:500 to account for potential affinity differences.

Which cell types or tissues express high levels of PCOLCE-1 for positive controls?

PCOLCE-1 is most abundant in connective tissues undergoing active collagen synthesis. Primary human dermal fibroblasts, osteoblasts, and chondrocytes are excellent cellular sources; collect conditioned medium after 24–48 hours in serum-free media for the cleanest Western blot signal. At the tissue level, skin, bone, cartilage, and blood vessels show strong expression. Fetal or neonatal tissues generally express higher levels than adult tissues. Avoid using cell lines with low collagen turnover, such as epithelial carcinoma lines, unless you have RNA-seq or proteomic evidence of PCOLCE-1 expression.

Are there PCOLCE-1 isoforms or splice variants I should know about?

The major isoform is the canonical 449-residue protein encoded by the full-length PCOLCE transcript. A shorter splice variant, PCOLCE-2, is encoded by a separate gene and shares structural homology but is functionally distinct, so this antibody will not cross-react with PCOLCE-2. Within PCOLCE-1 itself, minor splice variants have been reported in the literature but are not well characterized and unlikely to be detected at significant levels in most tissues. Focus on the approximately 48–55 kDa band; additional bands may represent degradation products or non-specific binding rather than bona fide isoforms.

What sample preparation works best for detecting secreted PCOLCE-1?

Because PCOLCE-1 is secreted into the extracellular space, conditioned medium typically yields stronger signal than whole-cell lysate. Grow cells to 70–80% confluence, wash twice with PBS, then incubate in serum-free medium for 24–48 hours. Concentrate the conditioned medium 10- to 20-fold using a 10-kDa cutoff centrifugal filter to improve sensitivity. If working with tissue homogenates, include a protease inhibitor cocktail and consider separating the soluble and matrix-bound fractions; PCOLCE-1 may partition into both. For plasma or serum samples, dilute 1:5 to 1:10 before loading to avoid overwhelming the gel.

How should I store this PCOLCE-1 antibody and how long is it stable?

Store the antibody at –20°C in small aliquots to avoid repeated freeze-thaw cycles, which can reduce titre and increase aggregation. The stock solution typically contains glycerol or another cryoprotectant and remains stable for at least 12 months under these conditions. For day-to-day use, keep a working aliquot at 4°C for up to one month. Do not store diluted antibody in blocking buffer for more than a week, as preservative concentration drops and microbial contamination risk increases. If you see higher background or weaker signal over time, prepare a fresh aliquot.

What is the immunogen and epitope for this polyclonal PCOLCE-1 antibody?

This rabbit polyclonal was raised against a recombinant fragment corresponding to a large portion of the human PCOLCE-1 sequence, likely spanning residues within the CUB and netrin-like domains. The polyclonal nature means it recognizes multiple epitopes across that region, which generally improves sensitivity and resilience to post-translational modifications or mild denaturation. We have not mapped individual epitopes. Because it targets a broad immunogen, the antibody should detect both native and denatured PCOLCE-1, making it suitable for Western blot applications where antigen retrieval may alter epitope accessibility.

Validation imagery coming soon

Western blot validation figures for RP-PCOLE1 will be published here as they are produced in-house.

If you would like to see existing validation data for this antibody before publication, request a sample copy.

Also known as:

  • PCOLCE
  • PCPE-1
  • Procollagen C-endopeptidase enhancer 1
  • Procollagen COOH-terminal proteinase enhancer 1
  • Procollagen C-proteinase enhancer 1
  • Type 1 procollagen C-proteinase enhancer protein
  • Type I procollagen COOH-terminal proteinase enhancer
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →